Expression of Histo-blood Group A Type 1, 2 and 3 Antigens in Normal Skin and Extramammary Paget's Disease

Overview

Journal Acta Histochem Cytochem

Specialty Biochemistry

Date 2009 Jan 31

PMID 19180201

Citations 3

Authors

Aki Tanaka

Akihiko Kimura

Yuki Yamamoto

Koji Uede

Fukumi Furukawa

Affiliations

Soon will be listed here.

Abstract

The distribution of histo-blood group A type 1, 2 and 3 antigens was investigated using immunohistochemistry in normal human skin and extramammary Paget's disease (EMPD). We used monoclonal antibodies (mAbs) Bioclone-A (BA) and AR-1, which react with histo-blood group A type 1/2, and type 3 antigens, respectively. We found that A type 1, 2 and 3 antigens were expressed in the upper layer of the epidermis. We also found that the duct cells of the eccrine glands expressed A type 1/2 antigens and A type 3 antigens regardless of secretor status. The dark cells of the eccrine glands expressed A type 1, 2 and 3 antigens from A blood group secretors, but not from non-secretors. Apocrine glands, hair follicles and sebaceous glands did not express these antigens. Since these antigens were localized in the eccrine glands, we examined the possibility of a skin tumor marker. Interestingly, 7 out of 16 extramammary Paget's disease cases were immunopositive for these antigens. Six cases were accompanied by dermal invasion. Five cases without dermal invasion were immunonegative against these antigens. These results suggest that the expression of histo-blood group A antigens in EMPD are associated with a poor histopathological prognosis.

Citing Articles

A Positive Dermcidin Expression Is an Unfavorable Prognostic Marker for Extramammary Paget's Disease.

Ohmori S, Sawada Y, Saito-Sasaki N, Sato S, Minokawa Y, Sugino H Diagnostics (Basel). 2021; 11(6).

PMID: 34198581 PMC: 8231974. DOI: 10.3390/diagnostics11061086.

Galectin-4 N-Terminal Domain: Binding Preferences Toward A and B Antigens With Different Peripheral Core Presentations.

Quintana J, Delgado S, Nunez-Franco R, Canada F, Jimenez-Oses G, Jimenez-Barbero J Front Chem. 2021; 9:664097.

PMID: 33968903 PMC: 8097242. DOI: 10.3389/fchem.2021.664097.

Immunohistochemical analysis of CXCR4 expression in fibrohistiocytic tumors.

Toyozawa S, Yamamoto Y, Ishida Y, Kondo T, Nakamura Y, Furukawa F Acta Histochem Cytochem. 2010; 43(2):45-50.

PMID: 20514291 PMC: 2875858. DOI: 10.1267/ahc.10003.

References

DAVIDSOHN I, Ni L, STEJSKAL R . Tissue isoantigens A, B, and H in carcinoma of the pancreas. Cancer Res. 1971; 31(9):1244-50. View

Orntoft T, Wolf H, Clausen H, Dabelsteen E, Hakomori S . Blood group ABH-related antigens in normal and malignant bladder urothelium: possible structural basis for the deletion of type-2 chain ABH antigens in invasive carcinomas. Int J Cancer. 1989; 43(5):774-80. DOI: 10.1002/ijc.2910430505. View

Breimer M, Jovall P . Structural characterization of a blood group A heptaglycosylceramide with globo-series structure. The major glycolipid based blood group A antigen of human kidney. FEBS Lett. 1985; 179(1):165-72. DOI: 10.1016/0014-5793(85)80213-1. View

Denk H, Tappeiner G, Holzner J . Blood group substances (BG) as carcinofetal antigens in carcinomas of the distal colon. Eur J Cancer (1965). 1974; 10(8):487-90. DOI: 10.1016/0014-2964(74)90071-1. View

Urso C, Bondi R, Paglierani M, Salvadori A, Anichini C, Giannini A . Carcinomas of sweat glands: report of 60 cases. Arch Pathol Lab Med. 2001; 125(4):498-505. DOI: 10.5858/2001-125-0498-COSG. View

Szulman A . The histological distribution of blood group substances A and B in man. J Exp Med. 1960; 111:785-800. PMC: 2137290. DOI: 10.1084/jem.111.6.785. View

Clausen H, Levery S, Nudelman E, Tsuchiya S, Hakomori S . Repetitive A epitope (type 3 chain A) defined by blood group A1-specific monoclonal antibody TH-1: chemical basis of qualitative A1 and A2 distinction. Proc Natl Acad Sci U S A. 1985; 82(4):1199-203. PMC: 397222. DOI: 10.1073/pnas.82.4.1199. View

Donald A . A-active trisaccharides isolated from A1 and A2 blood-group-specific glycoproteins. Eur J Biochem. 1981; 120(2):243-9. DOI: 10.1111/j.1432-1033.1981.tb05695.x. View

Yotsumoto S, Tsuyama S, Tashiro M, Murata F . Ultrastructural immunocytochemical studies of blood group substances in human eccrine glands. J Histochem Cytochem. 1990; 38(12):1815-21. DOI: 10.1177/38.12.2254646. View

10.

Wick M, Goellner J, Wolfe 3rd J, Su W . Adnexal carcinomas of the skin. I. Eccrine carcinomas. Cancer. 1985; 56(5):1147-62. DOI: 10.1002/1097-0142(19850901)56:5<1147::aid-cncr2820560532>3.0.co;2-3. View

11.

Hakomori S . Antigen structure and genetic basis of histo-blood groups A, B and O: their changes associated with human cancer. Biochim Biophys Acta. 1999; 1473(1):247-66. DOI: 10.1016/s0304-4165(99)00183-x. View

12.

Gonzalez-Campora R, Jorda i Heras M, Salaverri C, Vazquez-Ramirez F, Galera-Davidson H . Blood group antigens in differentiated thyroid neoplasms. Arch Pathol Lab Med. 1998; 122(11):957-65. View

13.

DallOlio F . Protein glycosylation in cancer biology: an overview. Clin Mol Pathol. 1996; 49(3):M126-35. PMC: 408038. DOI: 10.1136/mp.49.3.m126. View

14.

Nosaka M, Ishida Y, Tanaka A, Hayashi T, Miyashita T, Kaminaka C . Aberrant expression of histo-blood group A type 3 antigens in vascular endothelial cells in inflammatory sites. J Histochem Cytochem. 2007; 56(3):223-31. PMC: 2324182. DOI: 10.1369/jhc.7A7290.2007. View

15.

Sanchez-Mora N, Cebollero Presmanes M, Monroy V, Herranz Aladro M, Alvarez-Fernandez E . Expression of histo-blood group antigens in bronchial squamous metaplasia. Eur Respir J. 2006; 29(2):268-72. DOI: 10.1183/09031936.00009806. View

16.

Ernst C, Thurin J, Atkinson B, WURZEL H, Herlyn M, Stromberg N . Monoclonal antibody localization of A and B isoantigens in normal and malignant fixed human tissues. Am J Pathol. 1984; 117(3):451-61. PMC: 1900579. View

17.

Kageshita T, Egawa K, Nagano H, Ono T, Arao T, Nakajima T . [Immunohistochemical study of the distribution of blood group antigens A, B and H in normal skin]. Nihon Hifuka Gakkai Zasshi. 1986; 96(7):705-10. View

18.

Dabelsteen E, Gao S . ABO blood-group antigens in oral cancer. J Dent Res. 2004; 84(1):21-8. DOI: 10.1177/154405910508400103. View

19.

Nakagoe T, Nanashima A, Sawai T, Tuji T, Ohbatake M, Jibiki M . Expression of blood group antigens A, B and H in carcinoma tissue correlates with a poor prognosis for colorectal cancer patients. J Cancer Res Clin Oncol. 2000; 126(7):375-82. DOI: 10.1007/pl00008485. View

20.

Le Pendu J, Marionneau S, Rocher J, Clement M . ABH and Lewis histo-blood group antigens in cancer. APMIS. 2001; 109(1):9-31. DOI: 10.1111/j.1600-0463.2001.tb00011.x. View